Browsing byAuthorThomas Broome, S
Showing results 1 to 8 of 8
| Issue Date | Title | Author(s) |
| 2023-07-05 | Altered Hippocampal and Striatal Expression of Endothelial Markers and VIP/PACAP Neuropeptides in a Mouse Model of Systemic Lupus Erythematosus. | Lee, J; Thomas Broome, S; Jansen, MI; Mandwie, M; Logan, GJ; Marzagalli, R; Musumeci, G; Castorina, A |
| 2021-05-25 | Assessing the Anti-Inflammatory Activity of the Anxiolytic Drug Buspirone Using CRISPR-Cas9 Gene Editing in LPS-Stimulated BV-2 Microglial Cells | Thomas Broome, S; Fisher, T; Faiz, A; Keay, KA; Musumeci, G; Al-Badri, G; Castorina, A |
| 2020-12 | Dopamine: an immune transmitter. | Thomas Broome, S; Louangaphay, K; Keay, KA; Leggio, GM; Musumeci, G; Castorina, A |
| 2022-04-26 | Exploring the Pro-Phagocytic and Anti-Inflammatory Functions of PACAP and VIP in Microglia: Implications for Multiple Sclerosis. | Jansen, MI; Thomas Broome, S; Castorina, A |
| 2021-10-11 | PACAP and VIP Modulate LPS-Induced Microglial Activation and Trigger Distinct Phenotypic Changes in Murine BV2 Microglial Cells. | Karunia, J; Niaz, A; Mandwie, M; Thomas Broome, S; Keay, KA; Waschek, JA; Al-Badri, G; Castorina, A |
| 2022-09-28 | Pro-Inflammatory and Pro-Apoptotic Effects of the Non-Protein Amino Acid L-Azetidine-2-Carboxylic Acid in BV2 Microglial Cells. | Piper, JA; Jansen, MI; Thomas Broome, S; Rodgers, KJ; Musumeci, G; Castorina, A |
| 2022-12-07 | Systemic Rotenone Administration Causes Extra-Nigral Alterations in C57BL/6 Mice. | Thomas Broome, S; Castorina, A |
| 2022-02-06 | The Anxiolytic Drug Buspirone Prevents Rotenone-Induced Toxicity in a Mouse Model of Parkinson's Disease. | Thomas Broome, S; Castorina, A |
